Abarelix

Product Name: Abarelix (CAS NO.183552-38-7)

IUPAC Name: (2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-3-hydroxypropanoyl]-methylamino]-3-(4-hydroxyphenyl)propanoyl]amino]-N-[(2S)-1-[[(2S)-1-[(2S)-2-[[(2R)-1-amino-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-6-(propan-2-ylamino)hexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]butanediamide
Molecular Formula: C₇₂H₉₅ClN₁₄O₁₄
Molecular Weight: 1416.06g/mol
Mol File: 183552-38-7.mol
Boiling point: 1688.37 °C at 760 mmHg
Flash Point: 974.891 °C
Density: 1.287 g/cm³
Surface Tension: 60.813 dyne/cm
Enthalpy of Vaporization: 280.205 kJ/mol
XLogP3-AA: 3.7
H-Bond Donor: 13
H-Bond Acceptor: 16

  Abarelix (CAS NO.183552-38-7) is primarily used in oncology to reduce the amount of testosterone made in patients with advanced symptomatic prostate cancer for which no other treatment options are available.

 Abarelix , its CAS NO. is 183552-38-7, the synonyms are N-Acetyl-3-(2-naphthyl)-D-alanyl-4-chloro-D-phenylalanyl-3-
(3-pyridyl)-D-alanyl-L-seryl-N-methyl-L-tyrosyl-D-asparaginyl-L-leucyl-N(sup 6)-isopropyl-L-lysyl-L-prolyl-D-alaninamide ; N-Acetyl-3-(2-naphthyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridyl)-D-alanyl-L-seryl-N-methyl-L-tyrosyl-D-asparginyl-L-leucyl-N6-isopropyl-L-lysyl-L-prolyl-D-alaninamide ; PPI 149 ; Plenaxis ; Plenaxis depot ; R 3827 ; UNII-W486SJ5824 ; D-Alaninamide, N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-N-methyl-L-tyrosyl-D-asparaginyl-L-leucyl-N6-(1-methylethyl)-L-lysyl-L-prolyl- 10 .